Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

2.7%

1 terminated/withdrawn out of 37 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

16%

6 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

13 recruiting1 with results

Enrollment Performance

Analytics

N/A
9(37.5%)
Phase 2
8(33.3%)
Phase 4
6(25.0%)
Phase 1
1(4.2%)
24Total
N/A(9)
Phase 2(8)
Phase 4(6)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (37)

Showing 20 of 37 trials
NCT07518810Phase 2Not Yet Recruiting

Efficacy and Safety of Butylphthalide in the Treatment of Multiple System Atrophy

Role: collaborator

NCT07507825Phase 2Not Yet Recruiting

Exploratory Study of Venetoclax, Homoharringtonine, Azacitidine Plus G-CSF for Newly Diagnosed AML (VHAG)

Role: collaborator

NCT07439757Recruiting

AI-Powered Precision Decision-Making for Pancreatic Diseases

Role: collaborator

NCT07395596Phase 4Recruiting

Remimazolam for Bronchoscopy in High-Risk Patients

Role: collaborator

NCT07177586Not ApplicableRecruiting

New-Generation GMA Laryngeal Mask Airway Versus Conventional Inflatable Laryngeal Mask Airway

Role: collaborator

NCT06596005Phase 2Completed

Efficacy and Safety of TJ0113 Capsule in Patients With Parkinson's Disease

Role: collaborator

NCT07266168Not ApplicableNot Yet Recruiting

Efficacy and Safety of Ivarmacitinib in the Treatment of Patients With Polymyalgia Rheumatica

Role: collaborator

NCT03957707Not ApplicableActive Not Recruiting

Sterotactic Operation Integrating With Thrombolysis in Basal Ganglion Hemorrhage Evacuation

Role: collaborator

NCT07195812Phase 4Not Yet Recruiting

Rivaroxaban for Slow Coronary Flow After PCI in STEMI

Role: collaborator

NCT07078500Phase 2Recruiting

Orelabrutinib Combined With Pola-R-CHP Regimen for the Treatment of Untreated Non-GCB Diffuse Large B-Cell Lymphoma

Role: collaborator

NCT06968962Not ApplicableRecruiting

Comparison of Sequential to Initial Combination Therapy in PAH

Role: collaborator

NCT04624295Phase 4Recruiting

Early Antiplatelet Therapy After Hemorrhagic Infarction in Acute Ischemic Stroke Treated With Intravenous Thrombolysis (HITs)

Role: collaborator

NCT07022223Phase 2Recruiting

Orelabrutinib Combined With Rituximab as First-line Systemic Treatment for Marginal Zone Lymphoma

Role: collaborator

NCT05418218Recruiting

International Headache Registry Study

Role: collaborator

NCT06638866Recruiting

AI-powered Early Detection for Pancreatic Cancer Via Non-contrast CT in Opportunistic Screening Cohort

Role: collaborator

NCT06543602Recruiting

the Multi-modal Evaluation of Agitation in Critically Ill Patients Based on Remote Video-Ultra-sensitive Detection Wave

Role: collaborator

NCT06452823Enrolling By Invitation

Efficacy and Safety of Catheter Ablation of Atrial Fibrillation in Patients With Thyroid Hormone Stabilization

Role: lead

NCT04897126Phase 4Completed

Efficacy and Safety of Shexiang Baoxin Pill in Patients With Ischemia With Non-Obstructive Coronary Artery

Role: collaborator

NCT06374966Not Yet Recruiting

Real-world Study of Efficacy and Safety of Zonisamide in add-on Therapy for Patients With Focal Epilepsy

Role: collaborator

NCT06290817Phase 2Recruiting

Orelabrutinib Combined With R-CDOP for DLBCL Patients With High-risk of CNS Relapse Defined by CNS-IPI

Role: collaborator